FR2112248B1 - - Google Patents

Info

Publication number
FR2112248B1
FR2112248B1 FR7135265A FR7135265A FR2112248B1 FR 2112248 B1 FR2112248 B1 FR 2112248B1 FR 7135265 A FR7135265 A FR 7135265A FR 7135265 A FR7135265 A FR 7135265A FR 2112248 B1 FR2112248 B1 FR 2112248B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7135265A
Other versions
FR2112248A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2112248A1 publication Critical patent/FR2112248A1/fr
Application granted granted Critical
Publication of FR2112248B1 publication Critical patent/FR2112248B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7135265A 1970-10-02 1971-09-30 Expired FR2112248B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1461470 1970-10-02

Publications (2)

Publication Number Publication Date
FR2112248A1 FR2112248A1 (fr) 1972-06-16
FR2112248B1 true FR2112248B1 (fr) 1975-04-18

Family

ID=4402343

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7135265A Expired FR2112248B1 (fr) 1970-10-02 1971-09-30

Country Status (10)

Country Link
AU (1) AU464325B2 (fr)
BE (1) BE773408A (fr)
CA (1) CA960141A (fr)
DE (1) DE2147711A1 (fr)
ES (1) ES395573A1 (fr)
FR (1) FR2112248B1 (fr)
GB (1) GB1369821A (fr)
IL (1) IL37700A (fr)
NL (1) NL7113533A (fr)
ZA (1) ZA716148B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ179623A (en) * 1975-01-06 1978-03-06 Ciba Geigy Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund

Also Published As

Publication number Publication date
FR2112248A1 (fr) 1972-06-16
GB1369821A (en) 1974-10-09
IL37700A (en) 1975-05-22
IL37700A0 (en) 1971-11-29
CA960141A (en) 1974-12-31
ZA716148B (en) 1972-05-31
AU3405071A (en) 1973-04-05
DE2147711A1 (de) 1972-04-06
BE773408A (fr) 1972-04-04
NL7113533A (fr) 1972-04-05
ES395573A1 (es) 1974-12-01
AU464325B2 (en) 1975-08-21

Similar Documents

Publication Publication Date Title
AU1473870A (fr)
AU2044470A (fr)
AU2130570A (fr)
AU1833270A (fr)
AU1716970A (fr)
AU1517670A (fr)
AU2017870A (fr)
AU2085370A (fr)
AU1872870A (fr)
AU2144270A (fr)
AU2115870A (fr)
AU1832970A (fr)
AU1603270A (fr)
AU1689770A (fr)
AU1789870A (fr)
AU1086670A (fr)
AU1841070A (fr)
AU1591370A (fr)
AU1879170A (fr)
AU1969370A (fr)
AU2131570A (fr)
AU2130770A (fr)
AU1881070A (fr)
AU2119370A (fr)
AU1581370A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse